Sedentary Time as a Digital Biomarker

Sedentary time is the waking time a person spends sitting or reclining at very low energy expenditure. It is a distinct risk factor, not simply the absence of exercise.

Status
Validated
Unit
hours/day
Data type
Duration
Sensor
Accelerometer / inclinometer
Worn
Multiple

Evidence maturity

Graded with the V3 framework: whether the sensor measures accurately, whether the algorithm has been validated against a reference standard, and whether the measure has been shown to matter clinically.

Verification
Established
Analytical validation
Emerging
Clinical validation
Established

The construct is formally defined and its outcome evidence is strong, but measurement is split between intensity-based and posture-based methods that disagree, and only thigh-worn inclinometry matches the definition.

What is Sedentary Time

Sedentary time is waking behaviour performed while sitting, reclining or lying at an energy cost of roughly 1.5 metabolic equivalents or below. The internationally agreed terminology, published by the Sedentary Behaviour Research Network, is deliberately precise on two points: the behaviour requires a sitting or reclining posture, and it excludes sleep. That distinction matters because a person can meet physical activity guidelines and still spend most of their waking day seated, and the two carry independent associations with cardiometabolic risk and mortality. As a digital biomarker, sedentary time is measured rather than recalled, and it also exposes pattern rather than total: how the sitting is accumulated, and how often it is broken up, is measurable only with a sensor. In clinical populations it functions as an indicator of functional limitation and disease burden.

How it is measured

Two approaches exist and they do not measure the same thing. Intensity-based methods classify epochs below an acceleration threshold as sedentary, historically fewer than 100 counts per minute on a hip-worn device. Posture-based methods use a thigh-worn inclinometer to detect whether the participant is actually sitting, and this is the reference approach because it matches the definition directly. The difference is not academic: standing still is not sedentary behaviour, but an intensity threshold classifies it as such. Wrist-worn consumer devices, which are the most practical for long studies, are the weakest here because a still wrist is compatible with sitting, standing and quiet standing work. Protocols usually require a minimum daily wear time and report both total sedentary hours and the number of breaks in sedentary time.

Clinical use

Sedentary time is used across cardiometabolic, cardiac and neurological research as both an outcome and a mechanistic variable. Pooled cohort analyses have shown a dose-response relationship between sedentary time and mortality that is strongly moderated by physical activity, so trials increasingly report the two together rather than in isolation. In heart failure, stroke recovery and multiple sclerosis it captures functional limitation that a step count can mask. Interventions that aim to interrupt prolonged sitting often report breaks in sedentary time rather than total hours, since the pattern is what the intervention actually changes. In the public DiMe endpoint library sedentary time is registered across trials in cardiovascular and neurological populations, including as a primary endpoint.

Regulatory status

No standalone regulatory qualification to date. Sedentary time is defined by an international terminology consensus rather than by a regulator, and appears in registered trial protocols including as a primary outcome.

Limitations

The intensity-based and posture-based definitions produce different numbers from the same day, and the literature mixes them freely, so totals are frequently not comparable across studies. Wrist devices cannot reliably separate sitting from standing, which is the core distinction the construct requires. Sedentary time is also bounded by wear time, so incomplete wear inflates or deflates the total depending on how missing data are handled. Finally, in populations with severe functional limitation the measure can reflect capacity rather than choice, and should be interpreted alongside a functional assessment rather than as a behaviour.

References

  • Tremblay MS, et al. Sedentary Behavior Research Network terminology consensus project. Int J Behav Nutr Phys Act. 2017. ncbi.nlm.nih.gov
  • Ekelund U, et al. Dose-response associations between accelerometry measured physical activity and sedentary time and all cause mortality. BMJ. 2019. pubmed.ncbi.nlm.nih.gov
  • Healy GN, et al. Sedentary time and cardio-metabolic biomarkers in US adults: NHANES 2003-06. Eur Heart J. 2011. pubmed.ncbi.nlm.nih.gov
  • Kozey-Keadle S, et al. Validation of wearable monitors for assessing sedentary behavior. Med Sci Sports Exerc. 2011. pubmed.ncbi.nlm.nih.gov
Devices that capture it
Related instruments

Objective counterpart of the sitting and low activity items in self-reported activity questionnaires such as the SQUASH and the Physical Activity Scale for the Elderly.

Use case
Monitoring · Prognostic
Collect Sedentary Time and other digital biomarkers in one workflow. Or turn your research into a new digital biomarker?
Capture sitting patterns from wearables alongside patient reported outcomes in a single study workflow.

Collect your digital biomarker data in no time all under your own brand

Collect meaningful digital biomarker data from your patients with ease. Our platform connects with wearables, smartphones, and other digital health devices, helping you capture continuous, real world data for research or clinical use all within your own branded experience.

Learn More

Connect your Data Sources

Connect wearables, smartphones, and digital health devices to collect relevant biomarker data directly from your patients.
Learn More
We Guide

Collect Data Continuously

Capture passive and active digital biomarker data such as activity, sleep, heart rate, mobility, and other vital signals over time.
Learn More

Collect the Data that Matters

Collect the digital health data most relevant to your research or clinical program. Choose the measurements and data points that support your specific study objectives and use case.
Learn More

Monitor the Full Patient Journey

Collect longitudinal biomarker data throughout the patient journey, from onboarding and baseline assessment to ongoing monitoring and follow up.
Learn More
Build your own biomarker, gather
evidence and commerclise
support screenshot
Pallete Paints

Rapidly design and configure complex studies in one place.

Set up your study without the technical friction. Easily define and configure all the critical data points you need to collect from patient reported forms and clinical tests to remote wearables using our intuitive, centralised platform.
Clinical Trial Builder

Capture unified, multimodal data with automated workflows.

Utilise WeGuide Engage to build your required dataset effortlessly. Keep participants and clinicians actively involved through automated prompts, ensuring high compliance and consistent data capture across all modalities.
We Guide
We Guide
Toggle Right

Evaluate clinical algorithms instantly with AI powered tools.

Bypass the technical bottlenecks with our biomarker development studio. Seamlessly create, score, and evaluate complex algorithms with the click of a button, turning raw data into validated insights without bespoke coding.
We Guide

Distribute directly via our Class IIb certified platform.

Seamlessly transition from research to revenue. Commercialise your digital biomarker instantly on our regulatory approved infrastructure, making it immediately available for pharma, clinical trials, and real-world interventions.